Sakurako Oyama, Kendall J Arslanian, Maria Luisa Savo Sardaro, Rachel L Duckham, Erin E Kershaw, Ashlee N Wood, Ulai T Fidow, Take Naseri, Muagututia S Reupena, Katherine R Amato, Nicola L Hawley
{"title":"Gut microbial composition and diversity varies by <i>CREBRF</i> genotype among Samoan infants.","authors":"Sakurako Oyama, Kendall J Arslanian, Maria Luisa Savo Sardaro, Rachel L Duckham, Erin E Kershaw, Ashlee N Wood, Ulai T Fidow, Take Naseri, Muagututia S Reupena, Katherine R Amato, Nicola L Hawley","doi":"10.1152/physiolgenomics.00014.2024","DOIUrl":null,"url":null,"abstract":"<p><p>Over 40% of Samoans have at least one copy of the minor A allele at rs373863828 in encoding CREB3 regulatory factor (<i>CREBRF</i>), which is associated with increased body mass index (BMI) but decreased odds of type 2 diabetes mellitus. The mechanisms underlying this paradoxical effect remain unknown. We hypothesized that gut microbiota may play a role and examined associations between <i>CREBRF</i> genotype and gut microbial diversity and composition among Samoan infants. Fecal samples were collected from Samoan infants aged 0 (<i>n</i> = 23), 4 (<i>n</i> = 20), and 21 (<i>n</i> = 27) mo. Microbiota community structure was analyzed using 16S rRNA bacterial gene sequencing. Both cross-sectional and longitudinal analyses revealed no associations between <i>CREBRF</i> genotype and overall microbiome composition or diversity at 0 or 4 mo. Cross-sectional analysis at 21 mo revealed a significant association between genotype and unweighted UniFrac distances (<i>F</i><sub>1,24</sub> = 1.855, <i>R</i><sup>2</sup> = 0.072, <i>P</i> = 0.015). Longitudinal differential abundance analysis also revealed several differentially abundant taxa at 21 mo. Notably, the AG genotype was associated with a lower relative abundance of <i>Escherichia-Shigella</i> (β = -6.741, SE = 2.243, <i>P</i> = 0.004, <i>q</i> = 0.042). Significant genotype differences in gut microbiome composition and diversity at 21 mo suggest that gut microbiota may be involved in relationships between <i>CREBRF</i> genotype and metabolic health. No genotype differences were observed at 0 or 4 mo, suggesting that environmental and/or maternal variables have a greater influence on the gut microbiome in early infancy, and genotype effects emerge later. Further research should examine whether genotype differences in gut microbiota are associated with functional differences in metabolic or immune signaling pathways or energy extraction.<b>NEW & NOTEWORTHY</b> Missense variant rs373863828 in <i>CREBRF</i> is associated with higher odds of obesity but lower odds of diabetes among Polynesians. We examined associations between <i>CREBRF</i> genotype and gut microbial diversity and composition among Samoan infants and identified significant differences at age 21 mo but not at age 0 or 4 mo. These results suggest that gut microbiota may contribute to the mechanisms through which <i>CREBRF</i> genotype impacts metabolic health.</p>","PeriodicalId":20129,"journal":{"name":"Physiological genomics","volume":" ","pages":"473-484"},"PeriodicalIF":2.5000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12276851/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Physiological genomics","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1152/physiolgenomics.00014.2024","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/14 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Over 40% of Samoans have at least one copy of the minor A allele at rs373863828 in encoding CREB3 regulatory factor (CREBRF), which is associated with increased body mass index (BMI) but decreased odds of type 2 diabetes mellitus. The mechanisms underlying this paradoxical effect remain unknown. We hypothesized that gut microbiota may play a role and examined associations between CREBRF genotype and gut microbial diversity and composition among Samoan infants. Fecal samples were collected from Samoan infants aged 0 (n = 23), 4 (n = 20), and 21 (n = 27) mo. Microbiota community structure was analyzed using 16S rRNA bacterial gene sequencing. Both cross-sectional and longitudinal analyses revealed no associations between CREBRF genotype and overall microbiome composition or diversity at 0 or 4 mo. Cross-sectional analysis at 21 mo revealed a significant association between genotype and unweighted UniFrac distances (F1,24 = 1.855, R2 = 0.072, P = 0.015). Longitudinal differential abundance analysis also revealed several differentially abundant taxa at 21 mo. Notably, the AG genotype was associated with a lower relative abundance of Escherichia-Shigella (β = -6.741, SE = 2.243, P = 0.004, q = 0.042). Significant genotype differences in gut microbiome composition and diversity at 21 mo suggest that gut microbiota may be involved in relationships between CREBRF genotype and metabolic health. No genotype differences were observed at 0 or 4 mo, suggesting that environmental and/or maternal variables have a greater influence on the gut microbiome in early infancy, and genotype effects emerge later. Further research should examine whether genotype differences in gut microbiota are associated with functional differences in metabolic or immune signaling pathways or energy extraction.NEW & NOTEWORTHY Missense variant rs373863828 in CREBRF is associated with higher odds of obesity but lower odds of diabetes among Polynesians. We examined associations between CREBRF genotype and gut microbial diversity and composition among Samoan infants and identified significant differences at age 21 mo but not at age 0 or 4 mo. These results suggest that gut microbiota may contribute to the mechanisms through which CREBRF genotype impacts metabolic health.
期刊介绍:
The Physiological Genomics publishes original papers, reviews and rapid reports in a wide area of research focused on uncovering the links between genes and physiology at all levels of biological organization. Articles on topics ranging from single genes to the whole genome and their links to the physiology of humans, any model organism, organ, tissue or cell are welcome. Areas of interest include complex polygenic traits preferably of importance to human health and gene-function relationships of disease processes. Specifically, the Journal has dedicated Sections focused on genome-wide association studies (GWAS) to function, cardiovascular, renal, metabolic and neurological systems, exercise physiology, pharmacogenomics, clinical, translational and genomics for precision medicine, comparative and statistical genomics and databases. For further details on research themes covered within these Sections, please refer to the descriptions given under each Section.